AstraZeneca: Oxford Vaccine Provides “100% Protection” Against Severe Covid-19 Cases

In an interview with the Sunday Times newspaper, the company's CEO said the immunizer ensured "100% protection" against serious forms of Covid-19.

RIO DE JANEIRO, BRAZIL - The British pharmaceutical group AstraZeneca said it has found, after further research, "the winning formula" for its vaccine against Covid-19 developed with Oxford University, which the British regulatory agency should comment on in the coming days.

In an interview with the Sunday Times newspaper, the pharmaceutical company's CEO, Pascal Soriot, said that the immunizer ensured "100% protection" against serious forms of Covid-19. The vaccines developed by Pfizer/BioNTech and Moderna showed efficacy of 95% and 94%, respectively.

"We believe we have found the winning formula and how to achieve efficacy that, with two . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?